Quick Answer: Yes. A Chinese cosmetic manufacturer can support an EU brand’s CPNP work by supplying accurate formula, ingredient, manufacturing, quality and packaging information. It cannot, solely by being the manufacturer in China, replace the EU-established Responsible Person (RP), the qualified safety assessor or the brand’s final-market decisions. CPNP notification is one required step before EU market placement, not a product approval or a stand-alone certificate.
What does “CPNP compliance” actually mean?
The Cosmetic Products Notification Portal (CPNP) is the European Commission’s electronic system for the notifications specified in Article 13 of Regulation (EC) No 1223/2009. The Commission explains that the RP and, in certain cases, distributors submit information through the portal. The portal is free to use. Notification does not show that the Commission has approved a product.
Before an EU cosmetic goes on the market, the RP must also ensure the product is safe, has a qualified safety assessment and CPSR, has a PIF, complies with ingredient, labelling and claims rules, and meets applicable GMP requirements. Calling all these duties “CPNP registration” can obscure who is responsible for each part.
| Information or document | Manufacturer can usually provide | Final EU decision / control |
|---|---|---|
| Final formula and INCI data | Accurate composition, specifications and change history under agreed confidentiality | RP and assessor confirm product identity and safety evidence |
| Raw-material records | Supplier specifications, certificates and relevant SDSs | Assessor judges whether data are adequate |
| Finished-product evidence | Available stability, microbiology and packaging-compatibility reports | Assessor identifies gaps for the final product |
| Manufacturing / GMP | Method description, quality records and GMP statement/evidence | RP checks Article 8 and PIF documentation |
| Label artwork and claims | Technical facts, INCI names and pack specifications | Brand and RP approve EU label and claim substantiation |
| CPNP inputs | Data needed for product identification and safety response | RP or applicable distributor submits the notification |
Who is legally responsible when manufacturing occurs in China?
Article 4 requires a cosmetic product placed on the EU market to have an RP established within the Union. For an imported cosmetic, the importer is the RP for the specific product unless another EU-established person is designated by written mandate and accepts that role in writing, as the Regulation permits. The contract should identify the RP for each product and clarify whether the buyer is the importer, brand owner or distributor. A China-based factory’s export service does not by itself make that factory the EU RP.
| Party | What the party can do | What not to assume |
|---|---|---|
| Chinese OEM/ODM manufacturer | Provide truthful technical data and production records; cooperate with evidence requests | It is automatically the EU RP or safety assessor |
| EU importer or designated RP | Carry out Article 5 responsibilities, hold the PIF and notify under Article 13 | The factory’s CPNP service transfers statutory duties away |
| Qualified safety assessor | Prepare or sign CPSR Part B based on product-specific evidence | A generic factory certificate is a signed CPSR |
| Brand owner | Set market, claims, formula and packaging; contract for missing work | A supplier’s previous notification covers every private-label version |
| Distributor | Check applicable duties; notify in specified Article 13 circumstances | Every distributor has identical RP duties |
What documents should a brand request from its manufacturer?
Ask first for a final, version-controlled formula and ingredient nomenclature appropriate to the EU assessment. Agree how confidential percentages and supplier identities can be disclosed to the RP and assessor. Then request raw-material specifications, relevant COAs and SDSs, impurity information when relevant, finished-product specifications, batch records and documented manufacturing controls. Whether a particular item is necessary should be determined against Annex I, the final formulation and the assessor’s questions.
For the PIF, Article 11 requires a description that clearly identifies the product, the CPSR, a description of manufacturing and a statement on GMP compliance, claim substantiation where justified, and the relevant animal-testing data. The manufacturer may supply much of the underlying evidence, but the RP must ensure the PIF is complete and available at the labelled address. Our CPSR guide explains the assessor-facing evidence; the CPNP/CPSR/PIF comparison explains their different purposes.
Can the factory submit the CPNP notification for the brand?
Portal access and the legal duty should not be conflated. Article 13 assigns notification to the RP, and specified distributor situations have their own duties. A third-party service may help prepare data or operate under the RP’s authorised workflow, but the RP should verify the entry, retain records and control later changes. Ask who holds the portal account, who can amend the notification and how the final entry will be matched to the marketed product. Do not treat a portal screenshot as approval.
Before any submission, reconcile product name, category, formulation identifiers, responsible-person details, packaging image and emergency/medical response information with the final product and the Regulation’s Article 13 fields. If the brand changes fragrance, colour, pack or claims, the RP and assessor should determine whether the safety file, label or portal entry needs updating. A factory should notify its client promptly about controlled production changes.
What does GMP support prove—and not prove?
Article 8 requires manufacturing to comply with good manufacturing practice. The Commission’s harmonised-standards listing includes EN ISO 22716:2007 as a cosmetics GMP standard. Evidence of GMP supports the manufacturing part of compliance, but it is not a substitute for product-specific CPSR, PIF, labelling or notification. A certificate’s issuing body, scope and validity should be checked before a brand relies on it.
A workable handover process for international brands
Create a responsibility matrix before sampling: identify the brand decision-maker, China manufacturer, EU importer/RP, assessor, laboratory and label reviewer. Agree the exact product and document versions that each party will receive. Set a secure route for confidential formula data, a named owner for outstanding test results, and a sign-off gate for final artwork and CPNP information. Contracts should explain updates, access to records and response to adverse events, rather than merely promising “EU certification.”
For ingredient and claim checks, refer to our EU ingredient guide and EU claims guide. The broader Regulation 1223/2009 overview helps place CPNP in context.
Frequently asked questions
Can a China-based factory be the EU Responsible Person?
A factory solely established in China does not meet the Article 4 requirement that the RP be established within the EU. A distinct EU-established legal person can be appointed where the Regulation permits.
Does CPNP registration prove a product is safe?
No. Notification is not an approval. The RP must ensure the product has been assessed for safety and that the other applicable obligations are met.
Can one manufacturer dossier support several brand versions?
Underlying evidence may be reusable, but the RP and assessor must verify coverage of each final formula, packaging, intended use, label and claims.
Who pays for testing and safety assessment?
That is a commercial contract matter. Agree it explicitly; the legal requirement to have adequate evidence remains regardless of who pays.
Official sources and review
Regulation (EC) No 1223/2009; European Commission CPNP; European Commission cosmetics harmonised standards. Last reviewed: 28 September 2026. Editorial preparation: MOOYAM cosmetic compliance content team. Legal obligations are distinguished from suggested contract and handover practices.
MOOYAM provides cosmetic OEM/ODM manufacturing and technical-documentation support for international beauty brands. If you need to scope a product-specific EU evidence handover, contact us; the EU RP and assessor make their own regulatory and safety decisions.
Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or a qualified compliance professional before placing cosmetic products on the market.